JOHANNESBURG - The Health Department says the strong uptake of Lenacapavir is an encouraging sign that communities are embracing the groundbreaking HIV prevention drug.
The twice-yearly injection is expected to strengthen efforts to curb new HIV infections.
More than 16,000 people have received the jab since its rollout.
Gauteng has exceeded the initial rollout target.
"Up to so far, the uptake is quite satisfactory, meaning that the message has reached quite a number of people," said Health Minister Aaron Motsoaledi.